Free Trial

Candriam S.C.A. Reduces Stock Position in Healthcare Realty Trust Incorporated $HR

Healthcare Realty Trust logo with Finance background

Key Points

  • Candriam S.C.A. reduced its holdings in Healthcare Realty Trust by 10.8% during the first quarter, selling 186,211 shares and now owns approximately $26 million worth of the stock.
  • The company has recently disclosed a $0.24 quarterly dividend, representing a yield of 5.8%, despite a negative payout ratio of -83.48%.
  • Analysts have downgraded Healthcare Realty Trust's rating, with target prices falling; the current consensus rating is "Reduce" with an average target price of $16.40.
  • Looking to export and analyze Healthcare Realty Trust data? Unlock 5 Weeks of MarketBeat All Access for Just $5. Claim Your Limited-Time Discount.

Candriam S.C.A. reduced its stake in Healthcare Realty Trust Incorporated (NYSE:HR - Free Report) by 10.8% during the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,543,440 shares of the real estate investment trust's stock after selling 186,211 shares during the quarter. Candriam S.C.A. owned about 0.44% of Healthcare Realty Trust worth $26,084,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in HR. Golden State Wealth Management LLC purchased a new position in Healthcare Realty Trust in the first quarter worth about $26,000. Lazard Asset Management LLC bought a new stake in shares of Healthcare Realty Trust during the fourth quarter valued at approximately $45,000. Financial Gravity Asset Management Inc. purchased a new position in Healthcare Realty Trust in the 1st quarter worth approximately $48,000. UMB Bank n.a. lifted its position in Healthcare Realty Trust by 73.3% in the 1st quarter. UMB Bank n.a. now owns 3,024 shares of the real estate investment trust's stock valued at $51,000 after acquiring an additional 1,279 shares in the last quarter. Finally, Avalon Trust Co purchased a new stake in shares of Healthcare Realty Trust during the first quarter valued at $53,000.

Analyst Upgrades and Downgrades

HR has been the topic of a number of research reports. JPMorgan Chase & Co. dropped their price target on Healthcare Realty Trust from $18.00 to $17.00 and set a "neutral" rating on the stock in a research note on Thursday, June 26th. Wall Street Zen cut Healthcare Realty Trust from a "hold" rating to a "sell" rating in a research report on Saturday, May 31st. Wedbush cut their price target on Healthcare Realty Trust from $18.00 to $16.00 and set a "neutral" rating for the company in a research note on Monday, May 5th. Finally, Wells Fargo & Company lowered their price objective on shares of Healthcare Realty Trust from $16.00 to $15.00 and set an "underweight" rating on the stock in a research note on Monday, June 2nd. Four equities research analysts have rated the stock with a Hold rating and one has issued a Sell rating to the company's stock. Based on data from MarketBeat.com, Healthcare Realty Trust has a consensus rating of "Reduce" and an average target price of $16.40.

Get Our Latest Analysis on HR

Healthcare Realty Trust Trading Down 0.4%

Shares of HR traded down $0.07 during trading hours on Tuesday, reaching $17.06. 535,700 shares of the stock traded hands, compared to its average volume of 3,120,801. The company's 50-day moving average price is $16.12 and its two-hundred day moving average price is $15.88. The company has a market cap of $6.00 billion, a P/E ratio of -14.83 and a beta of 0.89. Healthcare Realty Trust Incorporated has a 52-week low of $14.09 and a 52-week high of $18.90.

Healthcare Realty Trust (NYSE:HR - Get Free Report) last issued its quarterly earnings data on Thursday, July 31st. The real estate investment trust reported $0.41 earnings per share for the quarter, beating analysts' consensus estimates of $0.40 by $0.01. The firm had revenue of $287.07 million during the quarter, compared to analyst estimates of $290.83 million. Healthcare Realty Trust had a negative return on equity of 7.70% and a negative net margin of 32.95%.During the same quarter last year, the business posted $0.38 earnings per share. Healthcare Realty Trust has set its FY 2025 guidance at 1.570-1.610 EPS. On average, research analysts forecast that Healthcare Realty Trust Incorporated will post 1.59 EPS for the current year.

Healthcare Realty Trust Cuts Dividend

The firm also recently announced a quarterly dividend, which will be paid on Thursday, August 28th. Stockholders of record on Thursday, August 14th will be paid a dividend of $0.24 per share. This represents a $0.96 dividend on an annualized basis and a dividend yield of 5.6%. Healthcare Realty Trust's dividend payout ratio is -83.48%.

Insider Buying and Selling at Healthcare Realty Trust

In related news, Director Thomas N. Bohjalian acquired 10,000 shares of the firm's stock in a transaction that occurred on Wednesday, August 13th. The stock was bought at an average price of $16.46 per share, for a total transaction of $164,600.00. Following the acquisition, the director directly owned 75,520 shares of the company's stock, valued at $1,243,059.20. This represents a 15.26% increase in their position. The acquisition was disclosed in a document filed with the SEC, which is available at this hyperlink. Insiders own 0.37% of the company's stock.

Healthcare Realty Trust Profile

(Free Report)

Healthcare Realty Trust, Inc provides real estate investment services. It owns, leases, manages, acquires, finances, develops, and redevelops income-producing real estate properties associated primarily with the delivery of outpatient healthcare services throughout the United States of America. The company was founded by David R.

Recommended Stories

Institutional Ownership by Quarter for Healthcare Realty Trust (NYSE:HR)

Should You Invest $1,000 in Healthcare Realty Trust Right Now?

Before you consider Healthcare Realty Trust, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Healthcare Realty Trust wasn't on the list.

While Healthcare Realty Trust currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Beginner's Guide To Retirement Stocks Cover

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Tesla’s Future Unleashed: Elon’s Robotics Move Changes Everything
Top Trades: Massive Gains and Costly Mistakes to Avoid
NVIDIA Earnings: All Signs Point to More Growth Ahead

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines